Results 31 to 40 of about 49,611 (279)

Management of anti-seizure medications in lactating women with epilepsy

open access: yesFrontiers in Neurology, 2022
Epilepsy is a common neurological disease. At present, there are about 70 million epilepsy patients in the world, half of them are women, and 30–40% of women with epilepsy are of childbearing potential. Patients with epilepsy who are of childbearing potential face more challenges, such as seizures caused by hormonal fluctuations and the risk of adverse
Rong Yan   +9 more
openaire   +3 more sources

Assessing anti-seizure medication efficacy with EEG biomarkers: A scoping review protocol

open access: yes, 2022
A scoping review protocol to determined which EEG biomarkers can be used to assess anti-seizure medication efficacy to prognosticate seizure outcomes in clinical ...
Ashley Reynolds
core   +1 more source

Bi-level VNS therapy with different therapy modes at night and daytime improves seizures and quality of life in a patient with drug-resistant epilepsy

open access: yesEpilepsy & Behavior Reports, 2023
Induction or aggravation of sleep apnea is a known side effect of vagus nerve stimulation (VNS). We report the case of a 44 year old male with drug-resistant epilepsy and depression who did not experience any seizure reduction after 1 year of VNS but a ...
Berthold R. Voges
doaj   +1 more source

The Effect of Anti-seizure Medications on the Propagation of Epileptic Activity: A Review [PDF]

open access: yesFrontiers in Neurology, 2021
The propagation of epileptiform events is a highly interesting phenomenon from the pathophysiological point of view, as it involves several mechanisms of recruitment of neural networks. Extensive in vivo and in vitro research has been performed, suggesting that multiple networks as well as cellular candidate mechanisms govern this process, including ...
Mohamed Khateb   +3 more
openaire   +3 more sources

Efficacy of levetiracetam for neonatal seizures in preterm infants

open access: yesBMC Pediatrics, 2018
Background Neonatal seizures remain a significant clinical problem, and therapeutic options are still not diverse with limited efficacy. Levetiracetam (LEV) is a relatively new and wide spectrum anti-seizure medication with favorable pharmacokinetics and
Ji Yoon Han   +4 more
doaj   +1 more source

“Resistance Is Futile”: A Pilot Study into Pseudoresistance in Canine Epilepsy

open access: yesAnimals, 2023
Epilepsy is a common neurological disorder in veterinary practice, complicated by frequent occurrence of medication-resistant epilepsy. In human medicine, it has been noted that some patients with medication-resistant epilepsy have in fact other reasons ...
Filip Kajin   +3 more
doaj   +1 more source

Anti-seizure medications and quality of life in person with epilepsy

open access: yesHeliyon, 2022
The goal of this study was to determine the effects of mono-, bi-, and polytherapy anti-seizure medications (ASMs) in terms of seizure reduction and quality of life (QOL) in persons with epilepsy (PWE).A cross-sectional observational study was conducted. All PWE with age
Rekha Dwivedi   +4 more
openaire   +3 more sources

The contribution of non-drug factors to fetal malformation in anti-seizure-medication-treated pregnancy

open access: yes, 2021
Purpose: To assess the possible contribution of factors in additional to intrauterine anti-seizure medication (ASM) exposure in the occurrence of fetal malformation in women with ASM-treated ...
FİLİZ, AHMET KEMAL   +4 more
core   +1 more source

Adherence to anti-seizure medications and associated factors among children with epilepsy at tertiary Hospital in Southwest Ethiopia: a cross-sectional study

open access: yesBMC Neurology, 2022
Background Childhood epilepsy causes a tremendous burden for the child, the family, society as well as the healthcare system. Adherence to anti-seizure medications (ASMs) is a key to treatment success.
Hawi Mohammed   +3 more
doaj   +1 more source

Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy. [PDF]

open access: yesNeurol Sci
IntroductionSeizures may occur in up to 30% of non-Hodgkin lymphoma patients who received anti-CD19 CAR T-cell therapy, yet the optimal anti-seizure medication (ASM) prevention strategy has not been thoroughly investigated.MethodsConsecutive patients ...
Pensato U   +14 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy